The University of Texas - Houston Stroke Training Program

这一竞争性续签申请要求为4名博士后实习生提供额外5年的支持 中风和脑血管疾病完成为期2年的奖学金。该计划的任务是开发 神经学家将成为中风和脑血管疾病的临床医生和科学家。中风数量保持不变 导致成人长期严重残疾的原因之一；迫切需要有效的治疗。的具体目标 培训计划是：(1)提供脑血管临床和实验室检查方面的正规培训 疾病。过去5年在T32培训补助金下的资助显著扩展了我们的 将中风计划纳入大学范围的中风学院。因此，继续提供5年的资金将 允许我们：1)为中风研究员提供不间断的研究-指导计划；2)培训 种族多元化的研究人员和内科科学家将对脑血管疾病的治疗产生影响 疾病。我们的总体目标是通过指导临床医生-科学家来改善对中风患者的护理 致力于研究脑血管疾病的病理生理学和流行病学 将这一知识应用于新的治疗进展和更好的中风护理提供模式。教师导师 经过精心挑选，提供脑血管疾病方面的多学科培训经验。 潜在的实习生必须完成神经学实习，并表现出对职业的承诺 开展脑血管疾病研究。

This competitive renewal application requests 5 additional years of support for 4 post-doctoral trainees in stroke and cerebrovascular disease to complete a 2 year fellowship. The program’s mission is to develop neurologists to become clinician-scientists in stroke and cerebrovascular disease. Stroke remains the number one cause of serious long-term adult disability; effective treatments are urgently needed. The specific aims of the training program are to: (1) provide formal training in clinical and laboratory investigation of cerebrovascular disease. The last 5 years of funding under the T32 Training Grant has resulted in significant expansion of our stroke program into a university-wide Stroke Institute. Continued funding for another 5 years would therefore allow us to: 1) provide uninterrupted growth of our research-mentoring program for stroke fellows; 2) train ethnically diverse researchers and physician-scientists who will make an impact on treating cerebrovascular disease. Our overall goal is to improve the care of stroke patients by mentoring clinician-scientists who will dedicate their careers to investigating the pathophysiology and epidemiology of cerebrovascular disease and applying this knowledge to new therapeutic advances and better stroke care delivery models. Faculty mentors have been carefully selected to provide a multidisciplinary training experience in cerebrovascular disease. Potential trainees must have completed a neurology residency and demonstrate a commitment to a career carrying out research in cerebrovascular disease.